Torrent Pharmaceuticals Ltd.
NSE: TORNTPHARM | BSE: 500420
₹4,571.20
₹-1.00
(-0.02%)
As on 12-Jun-2026IST
Market cap
₹1,54,837 Cr
Revenue (TTM)
₹13,980 Cr
P/E Ratio
71.6
P/B Ratio
18.5
Div. Yield
0.8 %
Quality Score
6/10
Growth Score
6/10
Valuation Score
3/10
Momentum Score
10/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹2,138 Cr
-
ROE
26.8 %
-
ROCE
19.3 %
-
Industry P/E
34.97
-
EV/EBITDA
37.7
-
Debt to Equity
1.8
-
Book Value
₹247.8
-
EPS
₹63.9
-
Face value
5
-
Shares outstanding
338,445,440
10 Years Aggregate
CFO
₹20,144.35 Cr
EBITDA
₹26,041.60 Cr
Net Profit
₹12,052.85 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Torrent Pharma
| 18.7 | 1.2 | 3.2 | 42.6 | 36.3 | 26.0 | 21.1 |
|
BSE Sensex
| -10.8 | -0.6 | -1.7 | -8.5 | 6.4 | 7.6 | 11.0 |
|
BSE Healthcare
| 9.1 | 1.2 | 7.9 | 7.7 | 25.1 | 13.2 | 12.3 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Torrent Pharma
| 12.6 | 46.3 | 48.7 | -5.4 | 17.3 | 52.0 | 4.1 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Torrent Pharma
|
4,571.2 | 1,54,837.1 | 13,979.7 | 2,138.2 | 24.6 | 26.8 | 71.6 | 18.5 |
| 5,298.0 | 63,322.2 | 14,712.3 | 2,353.1 | 17.8 | 17.7 | 27.5 | 4.6 | |
| 1,472.8 | 84,710.0 | 33,653.1 | 3,501.5 | 14.9 | 9.7 | 24.2 | 2.2 | |
| 419.0 | 67,843.1 | 16,927.0 | 368.8 | 8.8 | -0.6 | 175.9 | 2.0 | |
| 1,389.4 | 1,12,193.6 | 28,162.6 | 3,869.8 | 16.6 | 11.8 | 28.9 | 3.3 | |
| 1,275.4 | 1,06,328.5 | 33,700.2 | 4,144.2 | 13.0 | 11.4 | 25.3 | 2.8 | |
| 2,293.3 | 1,04,829.7 | 27,958.0 | 5,355.5 | 26.6 | 27.4 | 19.7 | 4.7 | |
| 2,381.1 | 98,270.3 | 14,277.6 | 1,926.4 | 19.1 | 12.8 | 51.4 | 6.0 | |
| 1,807.7 | 4,33,619.8 | 58,462.0 | 11,564.5 | 23.9 | 15.4 | 37.8 | 5.2 | |
| 1,104.7 | 1,11,123.5 | 27,148.4 | 5,026.4 | 21.9 | 20.7 | 22 | 4.1 |
Shareholding Pattern
View DetailsNews & Analysis
All News
2 min read•By Mohammed Ekramul Haque
Which stocks are vulnerable to Brexit?
4 min read•By Kumar Shankar Roy
3 min read•By Mohammed Ekramul Haque
2 min read•By Mohammed Ekramul Haque
2 min read•By Vikas Vardhan
4 min read•By Saurabh Mukherjea
About Torrent Pharma
Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally. The company offers... products in various therapeutic areas, including anti-diabetic, anti-microbial, cardiovascular, urology, gynecology, oncology, gastro-intestinal, nephrology, neuro-psychiatric, cosmo-dermatology, pain management, anti-infective, and miscellaneous, as well as vitamins, minerals, and nutrients. It also provides contract manufacturing services. The company offers its products under Tedibar, Shelcal, Unienzyme, and Ahaglow brands. The company was formerly known as Trinity Laboratories and changed its name to Torrent Pharmaceuticals Limited in 1971. The company was founded in 1959 and is based in Ahmedabad, India. Torrent Pharmaceuticals Limited is a subsidiary of Torrent Investments Limited. Read more
-
Incorporated
1972
-
Chairman
Samir Mehta
-
Managing Director
Aman Mehta
-
Group
Torrent
-
Headquarters
Ahmedabad, Gujarat
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Quarterly Updates
Annual Reports
FAQs for Torrent Pharma
What is the current share price of Torrent Pharmaceuticals Ltd Today?
The share price of Torrent Pharmaceuticals Ltd is ₹4,571.20 (NSE) and ₹4,574.95 (BSE) as of 12-Jun-2026 IST. Torrent Pharmaceuticals Ltd has given a return of 36.28% in the last 3 years.
What is the current PB & PE ratio of Torrent Pharmaceuticals Ltd?
The P/E ratio of Torrent Pharmaceuticals Ltd is 71.57 times as on 12-Jun-2026, a 105 premium to its peers’ median range of 34.97 times.
The P/B ratio of Torrent Pharmaceuticals Ltd is 18.46 times as on 12-Jun-2026, a 270 premium to its peers’ median range of 4.99 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2026
|
66.03
|
17.03
|
|
2025
|
57.28
|
14.42
|
|
2024
|
53.15
|
12.84
|
|
2023
|
41.79
|
8.40
|
|
2022
|
30.45
|
7.95
|
What is the 52 Week High and Low of Torrent Pharmaceuticals Ltd?
The 52-week high and low of Torrent Pharmaceuticals Ltd are Rs 4,712.90 and Rs 3,140.10 as of 14-Jun-2026.
What is the market cap of Torrent Pharmaceuticals Ltd?
Torrent Pharmaceuticals Ltd has a market capitalisation of ₹ 1,54,837 Cr as on 12-Jun-2026. As per SEBI classification, it is a Large Cap company.
Should I invest in Torrent Pharmaceuticals Ltd?
Before investing in Torrent Pharmaceuticals Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.